Literature DB >> 19003325

Orally tolerant CD4 T cells respond poorly to antigenic stimulation but strongly to direct stimulation of intracellular signaling pathways.

K Asai1, S Hachimura, T Toraya, S Kaminogawa.   

Abstract

The response of splenic CD4 T cells from ovalbumin (OVA)-specific T cell receptor (TCR) transgenic mice after long-term feeding of a diet containing this antigen was examined. These CD4 T cells exhibited a decreased response to OVA peptide stimulation, in terms of proliferation, interleukin-2 secretion, and CD40 ligand expression, compared to those from mice fed a control diet lacking OVA, demonstrating that oral tolerance of T cells had been induced through oral intake of the antigen. We investigated the intracellular signaling pathways, which were Ca/CN cascade and Ras/MAPK cascade, of these tolerant CD4 T cells using phorbol-12-myristate-13-acetate (PMA) and ionomycin, which are known to directly stimulate these pathways. In contrast to the decreased response to TCR stimulation by OVA peptide, it was shown that the response of splenic CD4 T cells to these reagents in the state of oral tolerance was stronger. These results suggest that splenic CD4 T cells in the state of oral tolerance have an impairment in signaling, in which signals are not transmitted from the TCR to downstream signaling pathways, and have impairments in the vicinity of TCR.

Entities:  

Year:  2001        PMID: 19003325      PMCID: PMC3449668          DOI: 10.1023/A:1014009328207

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  35 in total

1.  Primary response of naive CD4(+) T cells to amino acid-substituted analogs of an antigenic peptide can show distinct activation patterns: Th1- and Th2-type cytokine secretion, and helper activity for antibody production without apparent cytokine secretion.

Authors:  W Ise; M Totsuka; R Takato; S Hachimura; T Sato; A Ametani; Y Kumagai; S Habu; S Kaminogawa
Journal:  FEBS Lett       Date:  2000-01-07       Impact factor: 4.124

Review 2.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

3.  Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.

Authors:  A I Jaiswal; C Dubey; S L Swain; M Croft
Journal:  Int Immunol       Date:  1996-02       Impact factor: 4.823

Review 4.  Food allergy, oral tolerance and immunomodulation--their molecular and cellular mechanisms.

Authors:  S Kaminogawa
Journal:  Biosci Biotechnol Biochem       Date:  1996-11       Impact factor: 2.043

5.  Naive T cells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice.

Authors:  T Sato; T Sasahara; Y Nakamura; T Osaki; T Hasegawa; T Tadakuma; Y Arata; Y Kumagai; M Katsuki; S Habu
Journal:  Eur J Immunol       Date:  1994-07       Impact factor: 5.532

6.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

7.  The regulation of immune responses to dietary protein antigens.

Authors:  A M Mowat
Journal:  Immunol Today       Date:  1987

8.  Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.

Authors:  M H Sayegh; S J Khoury; W W Hancock; H L Weiner; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.

Authors:  M Roy; A Aruffo; J Ledbetter; P Linsley; M Kehry; R Noelle
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

10.  Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection.

Authors:  L J Berg; B Fazekas de St Groth; A M Pullen; M M Davis
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.